Torsemide

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 587 publications

NT-proBNP reference and cut-off values should be adjusted to patient's age in clinical practice - results of national representative survey POLSENIOR 2.

NT-proBNP reference and cut-off values should be adjusted to patient's age in clinical practice - results of national representative survey POLSENIOR 2.

Journal: Kardiologia polska

Published: May 15, 2026

Comparative effects of intravenous furosemide and torsemide on survival and length of hospital stay in acute heart failure.

Comparative effects of intravenous furosemide and torsemide on survival and length of hospital stay in acute heart failure.

Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego

Published: April 28, 2026

In brief: A bumetanide nasal spray (Enbumyst) for edema.

In brief: A bumetanide nasal spray (Enbumyst) for edema.

Journal: The Medical letter on drugs and therapeutics

Published: April 10, 2026

Real-world effectiveness and safety of torsemide and spironolactone fixed dose combination in Indian heart failure patients (RESTORE-HF study): a prospective, multicenter, observational study.

Real-world effectiveness and safety of torsemide and spironolactone fixed dose combination in Indian heart failure patients (RESTORE-HF study): a prospective, multicenter, observational study.

Journal: Therapeutic advances in cardiovascular disease

Published: March 17, 2026

In brief: A second subcutaneous furosemide infusor (Lasix ONYU) for heart failure.

In brief: A second subcutaneous furosemide infusor (Lasix ONYU) for heart failure.

Journal: The Medical letter on drugs and therapeutics

Published: March 07, 2026

Decongestion in chronic heart failure.

Decongestion in chronic heart failure.

Journal: JRSM cardiovascular disease

Published: February 22, 2026

Using Artificial Intelligence to Assess Treatment-Effect Heterogeneity in Pragmatic Cardiovascular Trials: Insights from TRANSFORM-HF.

Using Artificial Intelligence to Assess Treatment-Effect Heterogeneity in Pragmatic Cardiovascular Trials: Insights from TRANSFORM-HF.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention.

Dynamic changes and clinical significance of the gut microbiota and serum metabolites in breast cancer onset, progression and chemotherapy intervention.

Journal: Frontiers in oncology

Published: January 24, 2026

Comparison of loop diuretics for chronic heart failure: a systematic review and meta-analysis.

Comparison of loop diuretics for chronic heart failure: a systematic review and meta-analysis.

Journal: European journal of clinical pharmacology

Published: January 24, 2026

Molecularly imprinted metal-organic framework-based potentiometric sensor for sensitive detection of torsemide in dietary supplements and milk.

Molecularly imprinted metal-organic framework-based potentiometric sensor for sensitive detection of torsemide in dietary supplements and milk.

Journal: Food chemistry

Published: December 30, 2025

Torsemide and warfarin: A cautionary case of altered international normalized ratio and bleeding risk.

Torsemide and warfarin: A cautionary case of altered international normalized ratio and bleeding risk.

Journal: Indian journal of pharmacology

Published: December 11, 2025

Comprehensive guideline-directed medical therapy strategies on health status outcomes in patients with heart failure: the LAQUA-HF randomised clinical trial.

Comprehensive guideline-directed medical therapy strategies on health status outcomes in patients with heart failure: the LAQUA-HF randomised clinical trial.

Journal: Heart (British Cardiac Society)

Published: December 09, 2025

Showing 1-12 of 587

Last Updated: 06/30/2026